170 filings
Page 3 of 9
8-K
9cfr2t
2 Apr 21
Other Events
5:00pm
8-K
gw8520umftnf
29 Mar 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:01pm
8-K
nz13sn 8bbbj
29 Mar 21
Regulation FD Disclosure
9:18am
8-K
hbnfa2qtdy
5 Feb 21
Departure of Directors or Certain Officers
4:24pm
8-K
rt4yoyamubq
29 Jan 21
Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19
7:30am
8-K
n7oxw54gw4vuiyg4bx
22 Jan 21
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19
10:41am
8-K
6r8jzjh
19 Jan 21
Other Events
5:24pm
8-K
e2x9k39 k003n0zshmx
14 Jan 21
Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19
4:30pm
8-K
tikv fnogn
11 Jan 21
Regulation FD Disclosure
6:07am
8-K
i3whhh
7 Jan 21
Departure of Directors or Certain Officers
4:30pm
8-K
k3a9ughv9z5g3ecpe83i
31 Dec 20
Other Events
4:37pm
8-K
bidi 1xjxjx2a4
12 Nov 20
Results of Operations and Financial Condition
6:06am
8-K
4onr dg5k461pnvh
6 Nov 20
Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
9:05am
8-K
g98h8itkym4 0y8nfq
4 Nov 20
Humanigen Executes Licensing Agreement for Lenzilumabâ„¢ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines
4:45pm
8-K
9jc yhhvinmmucy7
7 Oct 20
Departure of Directors or Certain Officers
4:15pm
8-K
8873dfvv 6mc
21 Sep 20
Other Events
8:26am
8-K
23bhu inhn
11 Sep 20
Departure of Directors or Certain Officers
4:43pm
8-K
jcay9v3ie13nz78nr1uk
4 Sep 20
Other Events
4:36pm
8-K
tdb07i
10 Aug 20
Regulation FD Disclosure
9:08am
8-K
fi21z1rfywai8vvyozzd
3 Aug 20
Departure of Directors or Certain Officers
8:30am